Ljubimova; Julia Y.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ljubimova; Julia Y..The latest application filed is for "methods and compositions for efficient delivery through multiple bio barriers".

Company Profile

4.14.19

Ljubimova; Julia Y. - Studio City CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods And Compositions For Efficient Delivery Through Multiple Bio Barriers App 20200206304 - Holler; Eggehard ; et al.	2020-07-02
Polymalic Acid-based Nanobiopolymer Compositions App 20200155593 - Inoue; Satoshi ; et al.	2020-05-21
Polymalic acid-based nanobiopolymer compositions Grant 10,583,151 - Inoue , et al.	2020-03-10
Tumor Targeting Nanoagent For Imaging And Fluorescent Guided Resection Of Tumors App 20190076555 - Patil; Rameshwar ; et al.	2019-03-14
Polymalic Acid Based Nanoimmunoconjugates And Uses Thereof App 20190060479 - LJUBIMOVA; Julia Y. ; et al.	2019-02-28
Polymalic Acid-based Nanobiopolymer Compositions App 20170340659 - Inoue; Satoshi ; et al.	2017-11-30
Drug delivery of temozolomide for systemic based treatment of cancer Grant 9,827,325 - Patil , et al. November 28, 2	2017-11-28
Drug Delivery Of Temozolomide For Systemic Based Treatment Of Cancer App 20170274085 - Patil; Rameshwar ; et al.	2017-09-28
Drug delivery of temozolomide for systemic based treatment of cancer Grant 9,629,919 - Patil , et al. April 25, 2	2017-04-25
Polymalic acid-based nanobiopolymer compositions Grant 9,623,041 - Inoue , et al. April 18, 2	2017-04-18
Drug Delivery Of Temozolomide For Systemic Based Treatment Of Cancer App 20160175450 - Patil; Rameshwar ; et al.	2016-06-23
Drug delivery of temozolomide for systemic based treatment of cancer Grant 9,320,807 - Patil , et al. April 26, 2	2016-04-26
Polymalic acid-based multifunctional drug delivery system Grant 8,911,717 - Ljubimova , et al. December 16, 2	2014-12-16
Poly(beta malic acid) with pendant Leu-Leu-Leu tripeptide for effective cytoplasmic drug delivery Grant 8,795,648 - Ding , et al. August 5, 2	2014-08-05
Drug delivery of temozolomide for systemic based treatment of cancer Grant 8,785,371 - Patil , et al. July 22, 2	2014-07-22
Polymalic Acid-based Nanobiopolymer Compositions App 20140193398 - Inoue; Satoshi ; et al.	2014-07-10
Drug Delivery Of Temozolomide For Systemic Based Treatment Of Cancer App 20140161762 - Patil; Rameshwar ; et al.	2014-06-12
Polymalic Acid-based Multifunctional Drug Delivery System App 20140039125 - Ljubimova; Julia Y. ; et al.	2014-02-06
Polymalic acid-based multifunctional drug delivery system Grant 8,562,964 - Ljubimova , et al. October 22, 2	2013-10-22
Poly(beta Malic Acid) With Pendant Leu-leu-leu Tripeptide For Effective Cytoplasmic Drug Delivery App 20130084261 - Ding; Hui ; et al.	2013-04-04
Drug Delivery Of Temozolomide For Systemic Based Treatment Of Cancer App 20120328555 - Patil; Rameshwar ; et al.	2012-12-27
Poly(beta malic acid) with pendant leu-leu-leu tripeptide for effective cytoplasmic drug delivery Grant 8,309,614 - Ding , et al. November 13, 2	2012-11-13
Polymalic Acid-based Multifunctional Drug Delivery System App 20110212048 - Ljubimova; Julia Y. ; et al.	2011-09-01
Polymalic acid-based multi-functional drug delivery system Grant 7,935,677 - Ljubimova , et al. May 3, 2	2011-05-03
Poly(beta Malic Acid) With Pendant Leu-leu-leu Tripeptide For Effective Cytoplasmic Drug Delivery App 20110020371 - Ding; Hui ; et al.	2011-01-27
Monoclonal Antibodies For Inhibition Of Laminin-8 Expression To Inhibit Human Gliomas App 20090263379 - Ljubimova; Julia Y. ; et al.	2009-10-22
Antisense inhibition of laminin-8 expression to inhibit human gliomas Grant 7,547,511 - Ljubimova , et al. June 16, 2	2009-06-16
Polymalic Acid-Based Multi-Functional Drug Delivery System App 20070259008 - Ljubimova; Julia Y. ; et al.	2007-11-08
Antisense inhibition of laminin-8 expression to inhibit human gliomas App 20070105797 - Ljubimova; Julia Y. ; et al.	2007-05-10
Using overexpression of laminin alpha 4 subunit as a diagnostic and prognostic indicator of malignant tumors App 20020155440 - Ljubimova, Julia Y. ; et al.	2002-10-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.